Arkolith/Insider Trading/SWTX/Form 4

Edris Badreddin

Chief Operating OfficerSpringWorks Therapeutics, Inc. (SWTX) · full profile →Form 4 · filed Mar 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Sell(S)4K$55.12$198K170K
Mar 3, 2025Sell(S)12K$54.26$655K174K
Mar 3, 2025Sell(S)4K$53.12$208K186K
Mar 3, 2025Sell(S)400$56.20$22K170K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-021008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML